Does CAPIVASERTIB Cause Product use issue? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Product use issue have been filed in association with CAPIVASERTIB (TRUQAP). This represents 0.5% of all adverse event reports for CAPIVASERTIB.
8
Reports of Product use issue with CAPIVASERTIB
0.5%
of all CAPIVASERTIB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Product use issue From CAPIVASERTIB?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPIVASERTIB. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CAPIVASERTIB Cause?
Diarrhoea (278)
Rash (253)
Death (228)
Hyperglycaemia (152)
Nausea (96)
Vomiting (81)
Blood glucose increased (70)
Fatigue (67)
Malignant neoplasm progression (62)
Disease progression (61)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which CAPIVASERTIB Alternatives Have Lower Product use issue Risk?
CAPIVASERTIB vs CAPLACIZUMAB
CAPIVASERTIB vs CAPLACIZUMAB-YHDP
CAPIVASERTIB vs CAPMATINIB
CAPIVASERTIB vs CAPREOMYCIN
CAPIVASERTIB vs CAPSAICIN